Mutational analysis of two boys with the severe perinatally lethal Melnick-Needles syndrome

Helena H Santos1, Paula P Garcia, Latife Pereira

  • 1Serviço Especial de Genética, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Insights

Melnick-Needles syndrome (MNS) is a rare X-linked disorder. This study confirms filamin A gene (FLNA) mutations in boys with the lethal form of MNS, identifying a new mutation.

Area of Science:

  • Genetics
  • Molecular Biology
  • Medical Genetics

Background:

  • Melnick-Needles syndrome (MNS) is a rare X-linked dominant disorder.
  • It is caused by mutations in the filamin A gene (FLNA).
  • MNS is part of a spectrum of related disorders including frontometaphyseal dysplasia and otopalatodigital syndromes.

Observation:

  • MNS typically presents with bone dysplasia and facial changes in females.
  • Affected males can have a similar phenotype or a perinatally lethal disorder.
  • FLNA mutations in exon 22 have been identified in females with MNS.

Findings:

  • This study reports FLNA exon 22 mutation screening in two boys with the perinatally lethal form of MNS and their mothers.
  • A novel FLNA mutation (p.[Gly1176Asp]) was identified in one boy and his mother.
  • A previously known FLNA mutation (p[.Ser1199Leu]) was found in the second boy and his mother.
  • This is the first report confirming FLNA mutations in males with the perinatally lethal MNS phenotype.

Implications:

  • These findings expand the understanding of FLNA mutations and their role in MNS.
  • Confirms FLNA mutations as the cause of the perinatally lethal male phenotype of MNS.
  • Highlights the importance of genetic testing for FLNA mutations in affected families.